In this video, I will be talking about Teladoc (TDOC +2.77%) and the recent moves the company has been making. The stock itself isn't doing great at all. Year over year it is down 43%, and since its all-time high, it is down 60%. But a broken stock does not equal a broken company. You can find the full video below.
Broken stock
As Teladoc has shown us in its latest earnings report, it is still growing while its competitors are failing to keep up. Teladoc Health's organic revenue grew by 41% vs. 69% sequentially. The company reported total revenue of $503 million, up 108.7% year over year and 10.8% quarter over quarter. I compared Teladoc with Amwell a while back and showed that Teladoc is not only growing but also outgrowing its competitors. The main reason I can think of as to why the stock keeps dropping is that the market is afraid the growth story will not continue after the pandemic.
Execution is key
Teladoc was named as a vendor by Canada Health Infoway for its whole-person care services, which serves approximately 60% of Canada's population. The good news continues Down Under, because Philips and Teladoc have announced a strategic partnership to deliver comprehensive virtual healthcare solutions across hospitals and health systems in Australia and New Zealand.
And lastly, Teladoc ranked highest among direct-to-consumer providers in the J.D. Power 2021 U.S. Telehealth Satisfaction Study. This is the second time Teladoc has taken first place since J.D. Power created this category three years ago.
For the full insights do watch the video below.
*Stock prices used were the closing prices of Oct. 1, 2021. The video was published on Oct. 3, 2021.
